Imaging and size analysis revealed significantly reduced spheroid growth in the KAT2A-targeting sgRNA group compared to the NTC group, although complete tumor progression arrest was not achieved (Fig. 3e, f). This evidence concerns the gene KAT2A and neoplasm.